Bharat Biotech says completed final analysis for Covaxin, claims 77.8% efficacy
New Delhi (TIP): Hyderabad-based Bharat Biotech on Friday, July 2, said that it has completed the final Phase-3 analysis for Covaxin, its indigenous vaccine against the coronavirus disease (Covid-19). Citing pre-print data from “India’s largest […]
